Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
American Journal of Hematology
|
July 12, 2021
Romidepsin and lenalidomide-based regimens have efficacy in relapsed/refractory lymphoma: Combined analysis of two phase I studies with expansion cohorts
Neha Mehta-Shah, Matthew A Lunning, Alison J Moskowitz, et al.
Haematologica
|
October 19, 2023
Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study
Alexandra Rezazadeh, Aniko Szabo, Arushi Khurana, et al.
Blood Advances
|
June 9, 2026
Prognostic factors and survival outcomes in relapsed/refractory aggressive B-cell lymphomas treated with epcoritamab
Allison M Bock, Lei Feng, Ayushi Chauhan, et al.
Blood
|
March 3, 2026
Real-world outcomes for lisocabtagene maraleucel in patients with relapsed or refractory large B-cell lymphoma
Jennifer L Crombie, Sairah Ahmed, Matthew J Frigault, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 14, 2018
NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018
Steven M Horwitz, Stephen M Ansell, Weiyun Z Ai, et al.
Science Translational Medicine
|
June 21, 2019
Targetable genetic alterations of <i>TCF4</i> (<i>E2-2</i>) drive immunoglobulin expression in diffuse large B cell lymphoma
Neeraj Jain, Keenan Hartert, Saber Tadros, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 8, 2020
NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020
Neha Mehta-Shah, Steven M Horwitz, Stephen Ansell, et al.
Nature Communications
|
November 5, 2025
Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma
Sunandini Sharma, Roshia Ali, Alyssa Bouska, et al.
Haematologica
|
April 1, 2021
Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma
Man Chun John Ma, Saber Tadros, Alyssa Bouska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 27, 2021
Burkitt Lymphoma International Prognostic Index
Adam J Olszewski, Lasse H Jakobsen, Graham P Collins, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
American Journal of Hematology
|
July 12, 2021
Romidepsin and lenalidomide-based regimens have efficacy in relapsed/refractory lymphoma: Combined analysis of two phase I studies with expansion cohorts
Neha Mehta-Shah, Matthew A Lunning, Alison J Moskowitz, et al.
Haematologica
|
October 19, 2023
Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study
Alexandra Rezazadeh, Aniko Szabo, Arushi Khurana, et al.
Blood Advances
|
June 9, 2026
Prognostic factors and survival outcomes in relapsed/refractory aggressive B-cell lymphomas treated with epcoritamab
Allison M Bock, Lei Feng, Ayushi Chauhan, et al.
Blood
|
March 3, 2026
Real-world outcomes for lisocabtagene maraleucel in patients with relapsed or refractory large B-cell lymphoma
Jennifer L Crombie, Sairah Ahmed, Matthew J Frigault, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 14, 2018
NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018
Steven M Horwitz, Stephen M Ansell, Weiyun Z Ai, et al.
Science Translational Medicine
|
June 21, 2019
Targetable genetic alterations of <i>TCF4</i> (<i>E2-2</i>) drive immunoglobulin expression in diffuse large B cell lymphoma
Neeraj Jain, Keenan Hartert, Saber Tadros, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 8, 2020
NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020
Neha Mehta-Shah, Steven M Horwitz, Stephen Ansell, et al.
Nature Communications
|
November 5, 2025
Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma
Sunandini Sharma, Roshia Ali, Alyssa Bouska, et al.
Haematologica
|
April 1, 2021
Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma
Man Chun John Ma, Saber Tadros, Alyssa Bouska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 27, 2021
Burkitt Lymphoma International Prognostic Index
Adam J Olszewski, Lasse H Jakobsen, Graham P Collins, et al.
Page
of 7